Dayli Partners is an investment firm located in Seoul, Seoul-t'ukpyolsi, South Korea. Founded on January 1, 2018, the firm operates primarily in the Asia-Pacific (APAC) region. With a focus on biotech, pharma, and Biomed sectors, Dayli Partners has made notable investments in companies such as Genoplan, Galux, PharmCADD, and Medipixel. These investments highlight the firm's commitment to supportin...